|1.||Poljak-Blazi, Marija: 3 articles (01/2009 - 12/2003)|
|2.||Poljak-Blazi, M: 2 articles (12/2000 - 06/2000)|
|3.||Pivac, Nela: 1 article (01/2009)|
|4.||Mustapic, Maja: 1 article (01/2009)|
|5.||Jaganjac, Morana: 1 article (01/2009)|
|6.||Muck-Seler, Dorotea: 1 article (01/2009)|
|7.||Mihaljevic, Branka: 1 article (12/2006)|
|8.||Orescanin, Visnja: 1 article (12/2006)|
|9.||Zarkovic, Neven: 1 article (12/2006)|
|10.||Prutki, Maja: 1 article (12/2006)|
12/01/2006 - "Iron-containing antianemic drug ferric-sorbitol-citrate (FSC) inhibits the proliferation of various cancer cell lines in vitro and causes a regression of experimental murine tumors in vivo but does not affect the proliferation of nonmalignant cells. "
06/01/2000 - "We described before that iron-containing, anti-anaemic drug, ferric-sorbitol-citrate complex (FSC) inhibited proliferation of various murine cancer cells in vitro and caused tumour regression in vivo, but did not affect proliferation of the non-malignant cells. "
|4.||Melanoma (Melanoma, Malignant)
12/01/2003 - "Experimental arthritis was aggravated by ferric-citrate, whereas ferric-sorbitol-citrate did not promote it. "
12/01/2003 - "The effects of ferric-sorbitol-citrate and ferric-citrate on the severity of experimental arthritis, TNF-alpha secretion and the immune status were examined in mice. "
|2.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|3.||NF-kappa B (NF-kB)